(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide

C43H69N15O8 — CID 11205303

IUPAC(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide
SMILESCC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc2cnc[nH]2)CCCNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC1=O
InChIInChI=1S/C43H69N15O8/c1-25(2)19-33-42(66)58-34(20-27-11-5-4-6-12-27)38(62)51-23-35(59)49-17-9-14-32(41(65)57-33)56-40(64)31(15-10-18-50-43(46)47)55-39(63)30(13-7-8-16-44)54-36(60)26(3)53-37(61)29(45)21-28-22-48-24-52-28/h4-6,11-12,22,24-26,29-34H,7-10,13-21,23,44-45H2,1-3H3,(H,48,52)(H,49,59)(H,51,62)(H,53,61)(H,54,60)(H,55,63)(H,56,64)(H,57,65)(H,58,66)(H4,46,47,50)/t26-,29-,30-,31-,32-,33-,34-/m0/s1
InChIKeyUEIRPBYLWZBQAR-CIYBFAGOSA-N
MW924.12 g/mol
LogP-3.29
Rot. Bonds22

About (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide (PubChem CID 11205303) has the molecular formula C43H69N15O8 and a molecular weight of 924.12 g/mol. Its IUPAC name is (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide.

Molecular Properties

Compound Name(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide
PubChem CID11205303
Molecular FormulaC43H69N15O8
Molecular Weight924.12 g/mol
Exact Mass923.55
IUPAC Name(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide
SMILESCC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc2cnc[nH]2)CCCNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC1=O
InChIInChI=1S/C43H69N15O8/c1-25(2)19-33-42(66)58-34(20-27-11-5-4-6-12-27)38(62)51-23-35(59)49-17-9-14-32(41(65)57-33)56-40(64)31(15-10-18-50-43(46)47)55-39(63)30(13-7-8-16-44)54-36(60)26(3)53-37(61)29(45)21-28-22-48-24-52-28/h4-6,11-12,22,24-26,29-34H,7-10,13-21,23,44-45H2,1-3H3,(H,48,52)(H,49,59)(H,51,62)(H,53,61)(H,54,60)(H,55,63)(H,56,64)(H,57,65)(H,58,66)(H4,46,47,50)/t26-,29-,30-,31-,32-,33-,34-/m0/s1
InChIKeyUEIRPBYLWZBQAR-CIYBFAGOSA-N
XLogP-3.29
TPSA377.92 Ų
H-Bond Donors13
H-Bond Acceptors12
Rotatable Bonds22
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500924.12
LogP ≤ 5-3.29
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide?
The IUPAC name of (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide (CID 11205303) is (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide.
What is the SMILES notation for (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide?
The canonical SMILES for (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide is CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc2cnc[nH]2)CCCNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC1=O.
What is the InChIKey of (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide?
The InChIKey is UEIRPBYLWZBQAR-CIYBFAGOSA-N. The full InChI is InChI=1S/C43H69N15O8/c1-25(2)19-33-42(66)58-34(20-27-11-5-4-6-12-27)38(62)51-23-35(59)49-17-9-14-32(41(65)57-33)56-40(64)31(15-10-18-50-43(46)47)55-39(63)30(13-7-8-16-44)54-36(60)26(3)53-37(61)29(45)21-28-22-48-24-52-28/h4-6,11-12,22,24-26,29-34H,7-10,13-21,23,44-45H2,1-3H3,(H,48,52)(H,49,59)(H,51,62)(H,53,61)(H,54,60)(H,55,63)(H,56,64)(H,57,65)(H,58,66)(H4,46,47,50)/t26-,29-,30-,31-,32-,33-,34-/m0/s1.
What are the key properties of (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide?
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide has a molecular weight of 924.12 g/mol, XLogP of -3.29, 22 rotatable bonds, 13 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-1-[[(6S,9S,12S)-6-benzyl-9-(2-methylpropyl)-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclopentadec-12-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]hexanamide is sourced from PubChem (CID 11205303), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).